Resmed (RMD) Common Equity (2010 - 2026)
Resmed (RMD) reported Common Equity of $6.59 billion for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 10.3% from $5.97 billion a year earlier and up 1.4% from the prior quarter.
Resmed (RMD) Common Equity (2010 - 2026) Analysis & Trends
Dating back to fiscal Q4 2010, Resmed's Common Equity record includes 65 quarters.
- Common Equity has increased for 11 consecutive fiscal years, with a five-year compound annual growth rate of 17.9% (FY2021 to FY2026).
- By fiscal year, Common Equity came in at $5.97 billion in FY2025 (+22.7%), $4.86 billion in FY2024 (+17.8%), $4.13 billion in FY2023 (+22.9%) and $3.36 billion in FY2022 (+16.5%).
- The fiscal Q4 2026 figure ranks as the highest quarterly Common Equity in data going back to fiscal Q4 2010.
- Year over year, Common Equity has now increased in each of the last 29 quarters, with growth averaging 18.4% over the last eight quarters.
- Across the past five years, year-over-year growth in Common Equity ran from 9.8% in fiscal Q2 2022 to 23.8% in fiscal Q1 2024.
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $6.49 billion (Q3 2026), $6.32 billion (Q2 2026) and $6.12 billion (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 255.72 Bn | 234.75 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 180.50 Bn | 150.93 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 161.91 Bn | 145.72 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 151.39 Bn | 130.82 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 121.88 Bn | 87.13 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 116.40 Bn | 102.52 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 67.06 Bn | 61.82 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Becton Dickinson | 53.31 Bn | 50.46 Bn | 2.32 Bn | 24.42 Bn |
| 9 | Edwards Lifesciences | 51.33 Bn | 35.34 Bn | 1.35 Bn | 10.72 Bn |
| 10 | Resmed | 36.02 Bn | 30.09 Bn | 861.22 Mn | 6.59 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.59 Bn |
| Mar 31, 2026 | 6.49 Bn |
| Dec 31, 2025 | 6.32 Bn |
| Sep 30, 2025 | 6.12 Bn |
| Jun 30, 2025 | 5.97 Bn |
| Mar 31, 2025 | 5.55 Bn |
| Dec 31, 2024 | 5.25 Bn |
| Sep 30, 2024 | 5.20 Bn |
| Jun 30, 2024 | 4.86 Bn |
| Mar 31, 2024 | 4.63 Bn |
| Dec 31, 2023 | 4.48 Bn |
| Sep 30, 2023 | 4.25 Bn |
| Jun 30, 2023 | 4.13 Bn |
| Mar 31, 2023 | 3.93 Bn |
| Dec 31, 2022 | 3.74 Bn |
| Sep 30, 2022 | 3.43 Bn |
| Jun 30, 2022 | 3.36 Bn |
| Mar 31, 2022 | 3.28 Bn |
| Dec 31, 2021 | 3.15 Bn |
| Sep 30, 2021 | 3.03 Bn |
Resmed Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RMD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();